title: Oral acyclovir and neurologic adverse effects in endstage renal disease.
authors.forename: A L
authors.initials: AL
authors.lastname: Mataix
authors.forename: J
authors.initials: J
authors.lastname: Duarte
authors.forename: K
authors.initials: K
authors.lastname: Revuelta
authors.forename: M J
authors.initials: MJ
authors.lastname: Fuentes
authors.forename: M D
authors.initials: MD
authors.lastname: Ruiz
authors.forename: R
authors.initials: R
authors.lastname: Gavira
authors.forename: M C
authors.initials: MC
authors.lastname: López
mesh_terms: D000212:Acyclovir / Q000008:administration & dosage / Q000009:adverse effects*; D000284:Administration, Oral; D000368:Aged; D003128:Coma / Q000139:chemically induced; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D009207:Myoclonus / Q000139:chemically induced*; D009422:Nervous System Diseases / Q000139:chemically induced*; D006435:Renal Dialysis
chemical_list: D000212:Acyclovir